Areas of Expertise
  • Biopharma
  • Life Science Tools & Instrumentation
  • Genomics
  • SaaS
  • Public Companies
  • Mergers & Acquisitions
  • Venture Funding
Contact Linda Rubinstein
Download vCard
Recent Blog Posts
Fundraising Choices in Life Sciences: What, When & Why?
Read More
A Menu of Financing Alternatives for Life Science Companies
Read More

All Posts

Linda Rubinstein

Linda Rubinstein joined FLG in 2010 and serves on the Firm’s Management Committee. Linda has over 30 years of operational, financial and capital markets experience in life sciences, SaaS and investment banking. She has built particular expertise in the life sciences sector, notably biotechnology, life science tools, genomics and diagnostics. As CFO, Linda has overseen finance at research- and commercial-stage enterprises, consummated financing and M&A transactions, contributed to operations and strategy, and worked at private and public companies. As an investment banker, Linda completed over 30 transactions, raising over $5 billion in capital for companies ranging from emerging start-ups to Fortune 500 companies.

Prior to joining FLG, Linda was the sole principal of RDJ Advisors, providing interim CFO and other consulting services to life science and SaaS companies. Previously, as the CFO of Solexa, a publicly traded firm manufacturing and selling genetic analysis instrumentation, consumables and services, Linda was responsible for raising over $100 million in PIPE financings; building international staffing, implementing a new ERP system and establishing SOX-404 compliance; managing investor relations, human resources and certain legal matters; and negotiating the sale of Solexa to Illumina, Inc. in a $600 million stock-for-stock transaction announced in November 2006.

Earlier Linda served as Vice President of Finance at ChemoCentryx, a biotechnology company, and as Senior Vice President of Lehman Brothers’ Global Healthcare Investment Banking Group. Linda sat on the board of Sensorin, an analytical instrument company, from 2007 through 2014 and on non-profit boards JVS and Impact Bay Area.

Linda earned B.A. and M.A. degrees in Economics (summa cum laude and Phi Beta Kappa) from the University of California, Los Angeles.

Linda's Perspective on FLG

FLG allows me to better serve my clients in two ways.  I have a couple dozen partners who are available to help me serve my client better, with their referrals, introductions, experience and technical expertise.  And when I’m fully committed and can’t take on a new client, often one or more of my partners has the right skill set, experience and expertise to step in.

- Linda Rubinstein

Sector Experience
  • Biopharma
  • Diagnostics
  • Healthcare IT
  • Life Sciences
  • Medtech
  • SaaS
  • Technology
Selected Engagements
Kezar Life Sciences Biopharma Interim CFO Private
PaxVax Biopharma Permanent CFO
EpiBiome, Inc. Biopharma Interim CFO Private
Retrotope, Inc. Biopharma Interim CFO Private
ArmaGen, Inc. Biopharma Interim CFO Private
Tunitas Therapeutics, Inc. Biopharma Interim CFO Private
True North Therapeutics Life Sciences Permanent CFO Private
iPerian, Inc. Biopharma Interim CFO Private
Ingenuity Systems, Inc. Healthcare Services Permanent CFO Private
Past Directorships
Impact Bay Area
Videos Featuring Linda Rubinstein
CFO Priorities: From the IPO Organizational Meeting to Preparing the S-1
IPO Preparation: Additional IPO Workstreams Before You File Your S-1
IPOs for Life Science Companies: Key Considerations & Planning

View All Videos